But even with treatment, the disease can progress to the point ... One leading theory is that semaglutide may reduce ...

Sobi® and Apellis Pharmaceuticals, Inc. today announced positive one-year results from the phase 2 NOBLE study investigating systemic pegcetacoplan, a targeted C3 therapy, for the treatment of ...

“It is exciting to see that treatment with pegcetacoplan rapidly reduced disease ... Excessive C3c deposits are a marker of disease activity, which can lead to kidney inflammation, damage, and failure ...

Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with diabetes.

Coronary artery disease (CAD) is a condition where fatty material blocks the coronary arteries, leading to reduced blood flow ...

The introduction of semaglutide as a treatment could revolutionize the management ... potentially slowing the progression of ...

A second person in the U.S. was diagnosed this week with the H5N1 avian influenza virus. New research shows contaminated milk ...

Slayman underwent surgery at Massachusetts General Hospital on March 16 and received a pig kidney with 69 genomic edits. He lived dialysis-free for 52 days following the historic procedure. Williams ...

H.C. Wainwright analyst Arthur He CFA maintained a Buy rating on Calliditas Therapeutics (CALT – Research Report) today and set a price ...

You might have often noticed that the colour of urine turns yellow in summer. Yellow-coloured urine can be a sign of many ...

New real-world data will be presented that demonstrates treatment with pacritinib provides stability or improvement in thrombocytopenia and/or anemia in patients with myelofibrosis, regardless of ...

Emapalumab-lzsg is the first and only medicine approved in the US for primary HLH, a rare syndrome of hyperinflammation that can rapidly become fatal unless diagnosed and treated. Contacts For details ...